Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
23andMe said Monday it will lay off more than 200 employees, about 40% of its staff, and restructure the company amid its financial challenges. The genetic testing firm will discontinue the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback